Use of Post Operative Loperamide in Colorectal Patients After Diverting Ileostomies

Stopped early · Phase 3

Conditions studied: Dehydration, Diverting Ileostomy, Loperamide

In brief

Dehydration post creation of a diverting ileostomy is a common and debilitating problem faced by patients undergoing ileal-anal pouch anastomoses for both inflammatory bowel disease and familial adenomatous polyposis (FAP) syndrome. Those patients with low rectal cancers or other polyposis syndromes e.g. HNPCC hereditary non polyposis colorectal cancers, may potentially have a delay in the adjuvant therapy when faced with this complication. Studies performed in this groups of patients report a readmission rate of 17-21% for dehydration. Loperamide has been shown to significantly decrease the daily volume of weight of stool in these patients. The purpose of this study is to establish whether loperamide given at 4mg three times daily for 14 days from day of discharge empirically decreases 30 days readmission rate for dehydration. The investigators hypothesize that there will be a 15% decrease from 25% to 10% in the readmission rates, that severity of dehydration will be decreased.

Key facts

Study ID

NCT02263365

Run by

Cedars-Sinai Medical Center

People needed

40

Starts

2014-10-07

Expected to finish

2016-12-31

Last updated by the study team

2017-12-20

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Able to freely give written informed consent to participate in the study and have signed the Informed Consent Form;
• Males or females, age 18 and older at the time of study screening;
• American Society of Anesthesiologists (ASA) Class I-III (Appendix III) undergoing elective surgery

You may not qualify if…

• Mentally incompetent or unable or unwilling to provide informed consent or comply with study procedures
• American Society of Anesthesiologists (ASA) Class IV or V; emergency surgeries
• Children <18
• Pregnant patients
• Patients who have intra-abdominal sepsis or partial or intermittent bowel obstruction or enteritis
• Patients who are on long term steroids, opioids or antidiarrheals pre operatively
• Patients who are administered pro kinetics eg. Metoclopramide
• Patients with recurrent disease in their small bowel - Crohn's disease, or previous irradiated pelvis resulting in irradiation bowel disease
• End ileostomies

Where it is running

• Cedars Sinai Medical Center — Los Angeles, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.